Subscriber Metrics - End of Period Subscribers decreased by 8.8% year-over-year to 3.7 million, with a notable increase of 71.5% in Clinical Subscribers to 78,000[4] - Total end of period subscribers decreased to 3,667 in September 2024, down 8.8% from 4,022 in September 2023[25] - Digital subscribers at the end of the period were 3,043, a decline of 7.3% from 3,284 in the previous year[25] - Clinical subscribers increased significantly by 71.5% to 78 in September 2024, compared to 45 in September 2023[25] Revenue Performance - Revenues for Q3 2024 were 192.9million,reflectinga10.2191.2 million, down 6.0%[3] - Total revenues for the three months ended September 28, 2024, were 192,887,adecreaseof10.2214,871 for the same period last year[18] - Subscription revenues for the three months ended September 28, 2024, were 191,248,down6.3203,496 in the same period last year[18] - Year-to-date total revenues for 2024 were 601,508,down12.0683,594 in 2023[27] - Year-to-date digital subscription revenues were 399,364,adecreaseof8.7437,613 in 2023[27] - Other revenues plummeted 89.0% to 6,248in2024,comparedto56,927 in 2023[27] Profitability and Loss - Operating Loss for Q3 2024 was 39.0million,comparedtoanOperatingIncomeof30.6 million in the prior year, with Adjusted Operating Income at 35.7million[5]−NetLossforQ32024was46.2 million, compared to a Net Income of 43.7millionintheprioryear,resultinginaDilutedNetLosspershareof0.58[5] - Operating loss for the three months ended September 28, 2024, was (39,045),asignificantdeclinefromoperatingincomeof30,607 in the same period last year[18] - Net loss for the three months ended September 28, 2024, was (46,192),comparedtoanetincomeof43,731 in the same period last year[18] - The company experienced a 205.6% increase in net loss compared to the previous year[28] - Net Loss for YTD 2024 was (370,824),representinganincreaseof1,438.8(24,120) in YTD 2023[29] - Diluted Net Loss Per Share for YTD 2024 was (4.67),comparedto(0.32) in YTD 2023, marking an increase of 1,368.8%[29] Margins and Expenses - Gross Margin improved to 67.1%, up from 66.0% in the prior year, while Adjusted Gross Margin increased to 69.1% from 66.2%[4] - Gross Profit for Q3 2024 was 129,496thousand,withagrossmarginof67.1133,316 thousand, reflecting a gross margin of 69.1%[28] - Selling, general and administrative expenses totaled 67,094thousand,withanadjustedfigureof53,250 thousand[28] - Selling, General and Administrative Expenses decreased by 8.0% to 154,534inYTD2024from168,423 in YTD 2023[29] Cash and Assets - Cash balance as of September 28, 2024, was 57.2million,withnooutstandingborrowingsunderitsrevolvingcreditfacility[6]−Totalcurrentassetsdecreasedfrom179,474 million on December 30, 2023, to 101,228milliononSeptember28,2024,adeclineofapproximately43.5109,366 million to 57,181million,representingadecreaseofabout47.8315,033 for the nine months ended September 28, 2024[21] - The company reported a significant impairment charge of 54,295thousandrelatedtofranchiserightsacquired[28]−Thecompanyincurredimpairmentchargesof315 million related to franchise rights acquired in the first nine months of fiscal 2024[35] Guidance and Future Outlook - The Company is reiterating its full year fiscal 2024 guidance of at least 3.1 million total subscribers and revenues of at least 770.0million[7]−AdjustedOperatingIncomeguidanceforfiscal2024issetataminimumof100.0 million, excluding certain charges[7] - Forward-looking statements indicate potential risks related to competition and market dynamics in the weight management sector[15] - Future outlook includes ongoing restructuring efforts with associated charges impacting financial performance[28]